The power of embryonic stem cell transgenesis for experimental mammalian genetics

Endocrinology and Metabolism, Supplement

Volumn 3, Issue SUPPL. A, 1996, Pages 45-52

  Evans, Martin J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; EMBRYO CELL; EXPERIMENTAL ANIMAL; GENE INSERTION; GENE LOCUS; GENE TARGETING; MAMMAL; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RETROVIRUS; STEM CELL; TRANSGENE;

EID: 0029548212     PISSN: 1074939X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Evans MJ, Kaufman MH. Isolation and culture of pluripotential cells from early mouse embryos. Proceedings of the Anatomical Society of Great Britain and Ireland. J. Anat. 1981; 33: 107-108.
2. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292: 154-156.
3. Smithies O, Gregg RG, Boggs SS, Koralewski MA, Kucherlapati RS. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 1985; 317: 230-234.
4. Capecchi M. Altering the genome by homologous recombination. Science 1989; 244: 1288-1292.
5. Evans MJ. Potential for genetic manipulation of mammals. Mol. Biol. Med. 1989; 6: 557-566.
6. Evans MJ. Transgenic technologies. In: Kendrew J, Lawrence E, editors. The Encyclopedia of Molecular Biology. Oxford: Blackwell Science, 1994.
7. Evans MJ, Gilmour DT, Colledge WH. Transgenic rodents. In: McLean N, editor. Animals with Novel Genes. New York: Cambridge University Press, 1994.
8. Vogt TF, Jacksongrusby L, Wynshawboris AJ, Chan DC, Leder P. The same genomic region is disrupted in 2 transgene-induced limb deformity alleles. Mamm. Genome 1992; 3: 431-437.
9. Dorin JR, Stevenson BJ, Fleming S, Alton EW, Dickinson P, Porteous DJ. Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression. Mamm. Genome 1994; 5: 465-472.
10. Moens CB, Auerbach AB, Conlon RA, Joyner AL, Rossant J. A targeted mutation reveals a role for Nmyc in branching morphogenesis in the embryonic mouse lung. Genes Dev. 1992; 6: 691-704.
11. Kuehn MR, Bradley Am, Robertson ER, Evans MJ. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 1987; 326: 295-298.
12. Piquet PC, Grey L, Mereau A, Heath JK. Are LIF and related cytokines functionally equivalent? Exp. Cell Res. 1994; 213: 340-347.
13. Kontgen F, Stewart CL. Simple screening procedure to detect gene targeting events in embryonic stem cells. Methods Enzymol. 1993; 225: 878-890.
14. Ramirez-Solis R, Davis AC, Bradley A. Gene targeting in embryonic stem cells. Methods Enzymol. 1993; 225: 855-878.
15. Udy GB, Evans MJ. Microplate DMA preparation, PCR screening and cell freezing for gene targeting in embryonic stem cells. Biotechniques 1994; 17: 887-894.
16. Evans MJ. Tissue culture of embryonic stem cells. In: Celis J, editor. A Laboratory Handbook Cell Biology: New York: Academic Press, 1994.
17. Papaioannou VE, McBurney M, Gardner RL, Evans MJ. The fate of teratocarcinoma cells injected into early mouse embryos. Nature 1975; 258: 70-73.
18. Bradley A, Evans MJ, Kaufman MH, Robertson EJ. Formation of germ-line chimaeras from embryoderived teratocarcinoma cell lines. Nature 1984; 309: 255-256.
19. Wood SA, Allen ND, Rossant J, Auerbach A, Nagy A. Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature 1993; 365: 87-89.
20. Wood SA, Pascoe WS, Schmidt C, Kemler R, Evans MJ, Allen ND. Simple and efficient production of embryonic stem cell-embryo chimeras by coculture. Proc. Natl. Acad. Sei. USA 1993; 90: 4582-4585.
21. Nagy A, Rossant J, Nagy R, Abramow NW, Roder JC. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sei. USA 1993; 90: 8424-8428.
22. Robertson EJ, Bradley A, Kuehn M, Evans MJ. Germline transmission of genes introduced into cultured pluripotential cells by a retroviral vector. Nature 1986; 323: 445-448.
23. Hooper M, Hardy K, Handyside A, Hunter S, Monk M. Hprt-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 1987; 326: 292-295.
24. Conlon FL, Barth KS, Robertson EJ. A novel retrovirally induced embryonic lethal mutation in the mouse: assessment of the developmental fate of embryonic stem cells homozygous for the 413.d proviral integration. Development 1991; 111: 969-981.
25. Zhou X, Sasaki H, Löwe L, Hogan BLM, Kuehn MR. Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation. Nature 1993; 361: 543-547.
26. Joyner AL. Gene targeting and gene trap screens using embryonic stem cells: new approaches to mammalian development. Bioessays 1991; 13: 649-656.
27. Joyner AL, Auerbach A, Skarnes WC. The gene trap approach in embryonic stem cells: the potential for genetic screens in mice. Ciba Found. Symp. 1992; 165: 277-288.
28. Skarnes WC, Auerbach BA, Joyner AL A gene trap approach in mouse embryonic stem cells: the lacZ reported is activated by splicing, reflects endogenous gene expression, and is mutagenic in mice. Genes Dev. 1992; 6: 903-918.
29. Hill DP, Wurst W. Screening for novel pattern formation genes using gene trap approaches. Methods Enzymol. 1993; 225: 664-681.
30. Friedrich G, Soriano P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev. 1991; 5: 1513-1523.
31. von-Melchner H, DeGregori JV, Rayburn H, Reddy S, Friedel C, Ruley HE. Selective disruption of genes expressed in totipotent embryonal stem cells. Genes Dev. 1992; 6: 919-927.
32. Chang W, Hubbard SC, Friedel C, Ruley HE. Enrichment of insertional mutants following retrovirus gene trap selection. Virology 1993; 193: 737-747.
33. Chen Z, Friedrich GA, Soriano P. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev. 1994; 8: 2293-2301.
34. DeGregori J, Russ A, von-Melchner H, Rayburn H, Priyaranjan P, Jenkins NA, Copeland NG, Ruley HE. A murine homolog of the yeast RNA1 gene is required for postimplantation development. Genes Dev. 1994; 8: 265-276.
35. Rossant J, Hopkins N. Of fin and fur: mutational analysis of vertebrate embryonic development. Genes Dev. 1992; 6: 1-13.
36. Wurst W, Rossant J, Prideaux V, Kownacka M, Joyner A, Hill DP, Guillemot F, Gasca S, Cado D, Auerbach A. A large-scale gene-trap screen for insertional mutations in developmentally regulated genes in mice. Genetics 1995; 139: 889-899.
37. Reddy S, Rayburn H, von-Melchner H, Ruley HE. Fluorescence-activated sorting of totipotent embryonic stem cells expressing developmentally regulated lacZ fusion genes. Proc. Natl. Acad. Sei. USA 1992; 89: 6721-6725.
38. Skarnes WC, Moss JE, Hurtley SM, Beddington RSP. Capturing genes encoding membrane and secreted proteins important for mouse development. Proc. Natl. Acad. Sei. USA 1995; 92: 6592-6596.
39. Te-Riele H, Maandag ER, Berns A. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc. Natl. Acad. Sei. USA 1992; 89: 5128-5132.
40. Dewind N, Dekker M, Berns A, Radman M, Te-Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 1995; 82: 321-330.
41. Mombaerts P, Clarke AR, Hooper ML, Tonegawa S. Creation of a large genomic deletion at the T-cell antigen receptor -subunit locus in mouse embryonic stem cells by gene targeting. Proc. Natl. Acad. Sei. USA 1991; 88: 3084-3087.
42. Valancius V, Smithies O. Testing an 'in-out' targeting procedure for making subtle genomic modifications in mouse embryonic stem cells. Mol. Cell. Biol. 991; 11: 1402-1408.
43. Hasty P, Ramirez SR, Krumlauf R, Bradley A. Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature 1991; 350: 243-246.
44. Melton DW. Gene targeting in the mouse. Bioessays 1994; 16: 633-638.
45. Stacey A, Schnieke A, McWhir J, Cooper J, Colman A, Melton DW. Use of double-replacement gene targeting to replace the murine a-lactalbumin gene with its human counterpart in embryonic stem cells and mice. Mol. Cell. Biol. 1994; 14: 1009-1016.
46. Colledge WH, Abella BS, Southern KS, Ratcliff R, Jiang C, Cheng SH, MacVinish LJ, Anderson JR, Cuthbert AW, Evans MJ. Generation and characterization of a AF508 cystic fibrosis mouse model. Nature Genet. 1995; 10: 445-452.
47. Kilby NJ, Snaith MR, Murray JA. Site-specific recombinases: tools for genome engineering. Trends Genet. 1993; 9: 413-421.
48. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. Deletion of a DNA polymerase B gene segment in T cells using cell type-specific gene targeting. Science 1994; 265: 103-106.
49. Smith AJH, Desousa MA, Kwabiaddo B, Heppellparton A, Impey H, Rabbitts P. A site-directed chromosomal translocation induced in embryonic stem-cells by Cre-loxP recombination. Nature Genet. 1995; 9: 376-385.
50. Smithies O, Kim HS. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc. Natl. Acad. Sei. USA 1994; 91: 3612-3615.
51. Colucci GE, Portier MM, Dunia l, Paulin D, Pournin S, Babinet C. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 1994; 79: 679-694.
52. Gomi H, Yokoyama T, Fujimoto K, Ikeda T, Katoh A, Itoh T, Itohara S. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 1995; 14: 29-41.
53. Pekny M, Leveen P, Pekna M, Eliasson C, Bertholod CH, Westermark B, Betsholtz C. Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J. 1995; 14: 1590-1598.
54. Huang MT. Gene targeting technology for creating transgenic models of lymphopoiesis. Lab. Anim. Sei. 1993; 43: 156-159.
55. Yeung RS, Penninger J, Mak TW. T-cell development and function in gene-knockout mice. Curr. Opin. Immunol. 1994; 6: 298-307.
56. Pfeffer K, Mak TW. Lymphocyte ontogeny and activation in gene targeted mutant mice. Annu. Rev. Immunol. 1994; 12: 367-411.
57. Joyner AL, Guillemot F. Gene targeting and development of the nervous system. Curr. Opin. Neurobiol. 1994; 4: 37-42.
58. Millen KJ, Wurst W, Herrup K, Joyner AL. Abnormal embryonic cerebellar development and patterning of postnatal foliation in two mouse engrailed-2 mutants. Development 1994; 120: 695-706.
59. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, Berbacid M. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene [see comments]. Nature 1994; 368: 246-249.
60. Strittmatter SM, Fankhauser C, Huang PL, Mashimo H, Fishman MC. Neuronal pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP43. Cell 1995; 80: 445-452.
61. Krumlauf R, Marshall H, Studer M, Nonchev S, Sham MH, Lumsden A. Hox homeobox genes and régionalisation of the nervous system. J. Neurobiol. 1993; 24: 1328-1340.
62. Mark M, Lufkin T, Dolle P, Dierich A, LeMeur M, Chambon P. Roles of Hox genes: what we have learnt from gain of function and loss of function mutations in the mouse. C. R. Acad. Sei. lii 1993; 316: 995-1008.
63. Tybulewicz VL, Tremblay ML, LaMarca ME, Willemsen R, Stubblefield BK, Winfield S, Zablocka B, Sidransky E, Martin BM, Huang SP et al. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 1992; 357: 407-410.
64. Holleran WM, Ginns El, Menon GK, Grundmann JU, Fartasch M, McKinney CE, Elias PM, Sidransky E. Consequences of -glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J. Clin. Invest. 1994; 93: 1756-1764.
65. Ratcliff R, Evans MJ, Doran J, Wainwright BJ, Williamson R, Colledge WH. Disruption of the cystic fibrosis transmembrane conductance regulator gene in embryonic stem cells by gene targeting [Published erratum appears in Transgenic Res. 1993; 2: 60]. Transgenic Res. 1992; 1: 177-181.
66. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH. An animal model for cystic fibrosis made by gene targeting. Science 1992; 257: 1083-1088.
67. Dorin JR, Dickinson P, Alton EW, Smith SN, Geddes DM, Stevenson BJ, Kimber WL, Fleming S, Clarke AR, Hooper ML et al. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 1992; 359: 211-215.
68. O'Neal WK, Hasty P, McCray PJ, Casey B, Rivera PJ, Welsh MJ, Beaudet AL, Bradley A. A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus. Hum. Mol. Genet. 1993; 2: 1561-1569.
69. Colledge WH, Evans MJ. In: Lever AML, Goodfellow P, editors. British Medical Bulletin; Vol 51. Cystic fibrosis gene therapy. London: Churchill Livingstone, 1995: 82-90.